⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6420548 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL13082344 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL3318566 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL12658620 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL9623780 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL23872982 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL18726287 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL16297742 | 1.00 | PAOX (1.00) | — | |
| SCHEMBL18533504 | 1.00 | PAOX (1.00) | — | |
| Water SCHEMBL5510156 | 0.97 | PAOX (0.95) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114958291-B | Single-component high-adhesion room temperature vulcanized organosilicon sealant and preparation method thereof | 北京航空材料研究院股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| WO-2024133382-A1 | GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| US-20230357300-A1 | TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS | ADJUVANCE TECHNOLOGIES, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| US-20230357300-A1 | TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS | ADJUVANCE TECHNOLOGIES, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| WO-2023205272-A1 | PYRAZINAMIDE COMPOUNDS | THE GENERAL HOSPITAL CORPORATION (US) | 2023-10-26 | — | — | WO | disclosed |
| US-11786603-B2 | Optimized transglutaminase site-specific antibody conjugation | REGENERON PHARMACEUTICALS, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| CN-116850132-A | Formulations of active agents for oral administration | 安提拉生物有限公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-116831978-A | Formulations of active agents for oral administration | 安提拉生物有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116831977-A | Formulations of active agents for oral administration | 安提拉生物有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116790223-A | Single-component high-adhesion dealcoholized room temperature vulcanized organosilicon sealant and preparation method thereof | 北京航空材料研究院股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20070287670-A1 | HUMAN GLUCAGON-LIKE PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-12-13 | — | — | US | disclosed |
| WO-2007092363-A2 | HYBRID SLIP CASTING-ELECTROPHORETIC DEPOSITION (EPD) PROCESS | SAN DIEGO STATE UNIVERSITY (US) | 2007-08-16 | — | — | WO | disclosed |
| US-7238670-B2 | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-03 | — | — | US | disclosed |
| US-7238670-B2 | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-03 | — | — | US | disclosed |
| WO-2007058989-A2 | QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-05-24 | — | — | WO | disclosed |
| US-7183298-B2 | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors | TOPOTARGET UK LIMITED (GB) | 2007-02-27 | — | — | US | disclosed |
| WO-2006102069-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND GASTROINTESTINAL DISORDERS | MICROBIA, INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| US-6872827-B2 | Somatostatin analogue compounds | CHEMBRIDGE RESEARCH LABORATORIES, INC. (US) | 2005-03-29 | — | — | US | disclosed |
| WO-2004094461-A2 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2003033671-A2 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-04-24 | — | — | WO | disclosed |